StemCells Inc Share Price Nasdaq
Stocks
US85857R3030
Biotechnology & Medical Research
| Market Cap | 9.94Cr 8.57Cr 8.03Cr 7.33Cr 14Cr 950.04Cr 14Cr 95Cr 37Cr 479.58Cr 37Cr 37Cr 1.59TCr | P/E 2026 * |
-4.72x | P/E 2027 * | -4.31x |
|---|---|---|---|---|---|
| Enterprise Value | 9.94Cr 8.57Cr 8.03Cr 7.33Cr 14Cr 950.04Cr 14Cr 95Cr 37Cr 479.58Cr 37Cr 37Cr 1.59TCr | EV / Sales 2026 * |
62.2x | EV / Sales 2027 * | 11.3x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : StemCells Inc
| 1 day | -19.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 02/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 01/04/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 21/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 01/01/2013 |
Scott Burell
BRD | Director/Board Member | 61 | 28/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 06/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -19.35% | +575.21% | - | - | 9.94Cr | |
| -0.78% | -1.42% | +2.96% | +21.65% | 5.05TCr | |
| -6.00% | -0.75% | +447.48% | +535.14% | 4.46TCr | |
| -0.24% | +0.74% | +37.18% | +16.26% | 4.31TCr | |
| -1.55% | -2.07% | +19.83% | +71.70% | 4.17TCr | |
| -0.31% | -0.83% | +19.47% | +48.24% | 3.32TCr | |
| -1.79% | -3.24% | +26.32% | +125.06% | 1.68TCr | |
| -0.58% | -2.12% | - | - | 1.63TCr | |
| -0.88% | -0.66% | +11.63% | +27.62% | 1.46TCr | |
| -1.66% | -1.25% | +78.49% | +42.97% | 1.39TCr | |
| Average | -3.31% | -1.06% | +80.42% | +111.08% | 3.05TCr | |
| Weighted average by Cap. | -1.71% | -1.06% | +96.28% | +129.03% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.99L 13.78L 12.92L 11.79L 22.21L 15Cr 22.28L 1.53Cr 59.79L 7.71Cr 60.02L 58.72L 26Cr | 88L 75.83L 71.1L 64.9L 1.22Cr 84Cr 1.23Cr 8.44Cr 3.29Cr 42Cr 3.3Cr 3.23Cr 140.78Cr |
| Net income | -2.11Cr -1.82Cr -1.71Cr -1.56Cr -2.94Cr -201.97Cr -2.95Cr -20Cr -7.9Cr -101.95Cr -7.93Cr -7.76Cr -338.07Cr | -2.39Cr -2.06Cr -1.93Cr -1.76Cr -3.32Cr -228.64Cr -3.33Cr -23Cr -8.95Cr -115.42Cr -8.98Cr -8.79Cr -382.71Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
